Eris Lifesciences Ltd Stock Price Today (NSE: ERIS)
Fundamental Score
Eris Lifesciences Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Eris Lifesciences Ltd share price today is ₹1411.10, up +2.51% on NSE/BSE as of 17 June 2026. Eris Lifesciences Ltd (ERIS) is a Large-cap company in the Pharmaceuticals sector with a market capitalisation of ₹21.54K (Cr). The 52-week high for ERIS share price is ₹1885.00 and the 52-week low is ₹1200.00. At a P/E ratio of 51.82x, ERIS is currently trading above its industry average P/E of 31.77x. The company has a Return on Equity (ROE) of 12.88% and a debt-to-equity ratio of 0.77.
Eris Lifesciences Ltd Share Price Chart — NSE/BSE Historical Performance
Eris Lifesciences Ltd share price chart: -0.17% return over the past month. 52-week high ₹1885.00, 52-week low ₹1200.00.
Eris Lifesciences Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹1375.00 | ₹1395.50 | ₹1350.00 | ₹1362.10 | 40.06K (Cr) | |
| ₹1400.00 | ₹1413.00 | ₹1368.80 | ₹1378.40 | 46.57K (Cr) | |
| ₹1350.80 | ₹1403.00 | ₹1350.80 | ₹1399.00 | 1.75L (Cr) | |
| ₹1362.20 | ₹1374.90 | ₹1350.00 | ₹1350.80 | 37.41K (Cr) | |
| ₹1354.90 | ₹1370.00 | ₹1323.10 | ₹1361.40 | 1.06L (Cr) | |
| ₹1344.90 | ₹1358.00 | ₹1339.20 | ₹1353.50 | 63.91K (Cr) | |
| ₹1394.00 | ₹1397.90 | ₹1341.10 | ₹1343.80 | 1.29L (Cr) | |
| ₹1489.10 | ₹1530.00 | ₹1372.30 | ₹1385.90 | 6.66L (Cr) | |
| ₹1345.00 | ₹1495.00 | ₹1340.10 | ₹1458.20 | 16.05L (Cr) | |
| ₹1340.80 | ₹1356.40 | ₹1322.00 | ₹1336.20 | 41.10K (Cr) |
Eris Lifesciences Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹1400.00 | ₹1413.00 | ₹1350.00 | ₹1362.10 | -2.71% | |
| ₹1322.90 | ₹1530.00 | ₹1322.00 | ₹1399.00 | +5.75% | |
| ₹1312.90 | ₹1478.00 | ₹1200.00 | ₹1322.90 | +0.76% | |
| ₹1341.10 | ₹1375.90 | ₹1236.00 | ₹1297.20 | -3.27% | |
| ₹1375.00 | ₹1529.00 | ₹1316.20 | ₹1358.30 | -1.21% | |
| ₹1517.00 | ₹1563.00 | ₹1301.20 | ₹1375.50 | -9.33% | |
| ₹1586.00 | ₹1740.00 | ₹1469.10 | ₹1505.60 | -5.07% | |
| ₹1602.00 | ₹1700.00 | ₹1506.30 | ₹1595.40 | -0.41% | |
| ₹1585.00 | ₹1660.00 | ₹1520.00 | ₹1591.70 | +0.42% | |
| ₹1795.00 | ₹1810.80 | ₹1566.00 | ₹1585.90 | -11.65% | |
| ₹1808.40 | ₹1855.60 | ₹1630.00 | ₹1800.20 | -0.45% | |
| ₹1683.00 | ₹1885.00 | ₹1610.50 | ₹1798.90 | +6.89% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Eris Lifesciences Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Eris Lifesciences Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of ERIS across key market metrics for learning purposes.
Positive Indicators
6 factors identified
Strong Operating Margins (34.48%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Robust Profit Growth (31.23%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Consistent Growth Track Record (21.92% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Strong Cash Generation (₹1325.32 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Balanced Promoter Holding (54.85%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Strong Institutional Confidence (FII+DII: 26.57%)
Observation: Significant professional investor participation.
Analysis: High institutional holding often signals thorough due diligence.
Risk Factors
3 factors identified
Premium Valuation Risk (P/E: 51.82x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Weak Earnings Growth (3.65% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation.
Stagnant Profit Growth (3.71% CAGR)
Observation: Limited 5-year profit growth trajectory.
Analysis: Low profit growth may indicate scalability challenges or market maturity.
Eris Lifesciences Ltd vs Pharmaceuticals Peers
Peer Comparison - Pharmaceuticals
Compare Eris Lifesciences Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Eris Lifesciences LtdEris Lifescienc...Selected✓ ERIS • 540596 | 36.4/100 | ₹1411.10₹1411 | ₹21544.05₹21544.05 | 51.82Average 51.8 Average | 12.88%Average 12.88% Average | 12.22%Average 12.22% Average | 0.77Good 0.8 Good | 3.71%Average 3.71% Average | 21.92%Excellent 21.92% Excellent | 0.46% |
Sun Pharmaceutical Industries LtdSun Pharmaceuti... SUNPHARMA • 524715 | 65.2/100 | ₹1882.30₹1882 | ₹433738.68₹433738.68 | 37.57Average 37.6 Average | 16.86%Good 16.86% Good | 20.21%Excellent 20.21% Excellent | 0.07Excellent 0.1 Excellent | 23.78%Excellent 23.78% Excellent | 9.87%Good 9.87% Good | 0.89% |
Divis Laboratories LtdDivis Laborator... DIVISLAB • 532488 | 67.9/100 | ₹6797.50₹6798 | ₹170445.88₹170445.88 | 68.59Average 68.6 Average | 15.35%Good 15.35% Good | 20.44%Excellent 20.44% Excellent | 0.01Excellent 0.0 Excellent | 10.41%Good 10.41% Good | 11.65%Good 11.65% Good | 0.47% |
Torrent Pharmaceuticals LtdTorrent Pharmac... TORNTPHARM • 500420 | 65.3/100 | ₹4460.10₹4460 | ₹126430.62₹126430.62 | 58.36Average 58.4 Average | 26.52%Excellent 26.52% Excellent | 27.05%Excellent 27.05% Excellent | 0.33Excellent 0.3 Excellent | 13.84%Good 13.84% Good | 7.72%Good 7.72% Good | 0.86% |
Cipla LtdCipla Ltd... CIPLA • 500087 | 59/100 | ₹1418.20₹1418 | ₹123059.76₹123059.76 | 22.62Average 22.6 Average | 17.77%Good 17.77% Good | 22.72%Excellent 22.72% Excellent | 0.01Excellent 0.0 Excellent | 28.68%Excellent 28.68% Excellent | 9.97%Good 9.97% Good | 0.85% |
Dr Reddys Laboratories LtdDr Reddys Labor... DRREDDY • 500124 | 59.2/100 | ₹1335.20₹1335 | ₹105224.96₹105224.96 | 18.23Average 18.2 Average | 17.96%Good 17.96% Good | 22.69%Excellent 22.69% Excellent | 0.16Excellent 0.2 Excellent | 22.28%Excellent 22.28% Excellent | 13.26%Good 13.26% Good | 0.63% |
Lupin LtdLupin Ltd... LUPIN • 500257 | 66.7/100 | ₹2287.40₹2287 | ₹95148.15₹95148.15 | 22.00Average 22.0 Average | 20.62%Excellent 20.62% Excellent | 21.30%Excellent 21.30% Excellent | 0.32Excellent 0.3 Excellent | 54.88%Excellent 54.88% Excellent | 8.11%Good 8.11% Good | 0.58% |
Zydus Lifesciences LtdZydus Lifescien... ZYDUSLIFE • 532321 | 68.7/100 | ₹956.95₹957 | ₹94253.78₹94253.78 | 18.74Average 18.7 Average | 21.21%Excellent 21.21% Excellent | 24.31%Excellent 24.31% Excellent | 0.38Excellent 0.4 Excellent | 25.92%Excellent 25.92% Excellent | 10.27%Good 10.27% Good | 1.17% |
Mankind Pharma LtdMankind Pharma ... MANKIND • 543904 | 50.6/100 | ₹2492.60₹2493 | ₹92012.53₹92012.53 | 52.62Average 52.6 Average | 14.68%Average 14.68% Average | 15.98%Good 15.98% Good | 0.55Good 0.6 Good | 11.73%Good 11.73% Good | 15.79%Excellent 15.79% Excellent | 0.04% |
Aurobindo Pharma LtdAurobindo Pharm... AUROPHARMA • 524804 | 28.8/100 | ₹1435.90₹1436 | ₹70798.69₹70798.69 | 20.69Average 20.7 Average | 11.08%Average 11.08% Average | 14.18%Average 14.18% Average | 0.22Excellent 0.2 Excellent | 3.87%Average 3.87% Average | 6.55%Good 6.55% Good | 0.33% |
Alkem Laboratories LtdAlkem Laborator... ALKEM • 539523 | 59.5/100 | ₹5451.50₹5452 | ₹67075.29₹67075.29 | 28.54Average 28.5 Average | 19.39%Good 19.39% Good | 20.38%Excellent 20.38% Excellent | 0.18Excellent 0.2 Excellent | 13.93%Good 13.93% Good | 9.21%Good 9.21% Good | 0.80% |
Top Pharmaceuticals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Sun Pharmaceutical Industries Ltd share price433738.68 Cr
- Divis Laboratories Ltd share price170445.88 Cr
- Torrent Pharmaceuticals Ltd share price126430.62 Cr
- Cipla Ltd share price123059.76 Cr
- Dr Reddys Laboratories Ltd share price105224.96 Cr
Eris Lifesciences Ltd PE Ratio History
Historical price-to-earnings ratio for ERIS — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2025 | ₹25.81 | ₹1505.60 | 58.3x |
| FY 2024 | ₹28.79 | ₹1373.70 | 47.7x |
| FY 2023 | ₹28.07 | ₹910.00 | 32.4x |
| FY 2022 | ₹29.88 | ₹647.25 | 21.7x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Eris Lifesciences Ltd Dividend History
Annual cash dividends paid by ERIS — dividend yield 0.46%
| Financial Year | Dividends Paid (₹ Cr) |
|---|---|
| FY 2025 | ₹100.05 Cr |
| FY 2023 | ₹99.91 Cr |
| FY 2022 | ₹81.62 Cr |
| FY 2021 | ₹74.68 Cr |
Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.
Eris Lifesciences Ltd Quarterly Performance
Latest quarterly metrics for ERIS — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
6.91%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
31.23%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
21.92%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
3.71%
Compounded annual net profit growth over 5 years
Eris Lifesciences Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for ERIS — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Eris Lifesciences Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Eris Lifesciences Ltd (ERIS) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Eris Lifesciences Ltd
About ERIS (Eris Lifesciences Ltd)
Eris Lifesciences Ltd (ERIS) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Pharmaceuticals sector with a curr...ent market capitalisation of ₹21.54K (Cr). Eris Lifesciences Ltd has delivered a Return on Equity (ROE) of 12.88% and a ROCE of 12.22%. The debt-to-equity ratio stands at 0.77, reflecting the company's capital structure. Investors tracking ERIS share price can monitor key metrics including P/E ratio, promoter holding of 54.85%, and quarterly earnings growth.
Company Details
Key Leadership
Corporate Events
ERIS Share Price: Frequently Asked Questions
What is the current share price of Eris Lifesciences Ltd?
Eris Lifesciences Ltd (ERIS) trades at ₹1411.10 on NSE and BSE. Market cap ₹21.54K (Cr). Educational data only.
What is the P/E ratio of Eris Lifesciences Ltd?
Eris Lifesciences Ltd has a P/E of 51.82x vs industry average 31.77x.
What is the Bull Run score for Eris Lifesciences Ltd?
Eris Lifesciences Ltd has a Bull Run score of 36.4/100 based on 25+ financial parameters.
Does Eris Lifesciences Ltd pay dividends?
Eris Lifesciences Ltd has a dividend yield of 0.46%. Past dividends don't guarantee future payments.
What is the ROE of Eris Lifesciences Ltd?
Eris Lifesciences Ltd has ROE of 12.88%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Eris Lifesciences Ltd?
Eris Lifesciences Ltd has debt-to-equity of 0.77.
Is Eris Lifesciences Ltd a good investment?
Bull Run gives Eris Lifesciences Ltd a score of 36.4/100. This is not investment advice — consult a SEBI-registered advisor.